All terms in GO

Label Id Description
positive regulation of transcription regulatory region DNA binding GO_2000679 [Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.]
positive regulation of DNA binding GO_0043388 [Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).]
positive regulation of type B pancreatic cell apoptotic process GO_2000676 [Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process.]
regulation of DNA binding GO_0051101 [Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).]
negative regulation of myoblast fusion GO_1901740 [Any process that stops, prevents or reduces the frequency, rate or extent of myoblast fusion.]
regulation of myoblast fusion GO_1901739 [Any process that modulates the frequency, rate or extent of myoblast fusion.]
regulation of early endosome to late endosome transport GO_2000641 [Any process that modulates the frequency, rate or extent of early endosome to late endosome transport.]
positive regulation of myoblast fusion GO_1901741 [Any process that activates or increases the frequency, rate or extent of myoblast fusion.]
negative regulation of early endosome to late endosome transport GO_2000642 [Any process that stops, prevents or reduces the frequency, rate or extent of early endosome to late endosome transport.]
2-deoxystreptamine metabolic process GO_1901742 [The chemical reactions and pathways involving 2-deoxystreptamine.]
2-deoxystreptamine catabolic process GO_1901743 [The chemical reactions and pathways resulting in the breakdown of 2-deoxystreptamine.]
positive regulation of SREBP signaling pathway GO_2000640 [Any process that activates or increases the frequency, rate or extent of the SREBP signaling pathway.]
regulation of SREBP signaling pathway GO_2000638 [Any process that modulates the frequency, rate or extent of the SREBP signaling pathway.]
2-deoxystreptamine biosynthetic process GO_1901744 [The chemical reactions and pathways resulting in the formation of 2-deoxystreptamine.]
prephenate(2-) metabolic process GO_1901745 [The chemical reactions and pathways involving prephenate(2-).]
prephenate(2-) catabolic process GO_1901746 [The chemical reactions and pathways resulting in the breakdown of prephenate(2-).]
beta1-adrenergic receptor activity GO_0004940 [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta1-adrenergic receptors.]
beta-adrenergic receptor activity GO_0004939 [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta-adrenergic receptors; the activity involves transmitting the signal to the Gs alpha subunit of a heterotrimeric G protein.]
prephenate(2-) biosynthetic process GO_1901747 [The chemical reactions and pathways resulting in the formation of prephenate(2-).]
beta2-adrenergic receptor activity GO_0004941 [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta2-adrenergic receptors.]